Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Pneumococcal InfectionsPneumococcal Pneumonia
Interventions
BIOLOGICAL

Pneumococcal Vaccine

0.5 mL, intramuscular

BIOLOGICAL

Pneumococcal Vaccine

0.5 mL, intramuscular

BIOLOGICAL

Pneumococcal Vaccine

0.5 mL, intramuscular

Trial Locations (1)

Unknown

Allschwil

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY